Search results for "Cardiology"
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
MKSAP Quiz: Routine visit for HIV
A 44-year-old man is evaluated in the office during a routine visit. Medical history is significant for HIV diagnosed at age 25 years, hypertension, and hyperlipidemia. He is a current smoker. Following a physical exam, cardiac exam, and lab tests, what risk factors will result in underestimation of the risk for atherosclerotic cardiovascular disease in this patient?
https://immattersacp.org/weekly/archives/2019/03/19/3.htm
19 Mar 2019
Stopping preventive aspirin associated with 37% increased risk of cardiovascular events
Patients who continued aspirin had a 4.1% yearly incidence of cardiovascular events, compared to 5.4% among those who stopped taking the drug, while the risk of discontinuation corresponded to one additional cardiovascular event for every 74 patients who stopped taking aspirin in a year.
https://immattersacp.org/weekly/archives/2017/10/03/4.htm
3 Oct 2017
MKSAP Quiz: Treatment of elevated cholesterol levels
A 58-year-old man is evaluated during a routine visit. He has psoriatic arthritis and hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2021/12/14/3.htm
14 Dec 2021
Collaboration with heart failure patients key
Comanaging cardiology patients after heart failure requires small adjustments, following recent guidelines, and patient involvement in decisions.
https://immattersacp.org/archives/2021/07/collaboration-with-heart-failure-patients-key.htm
1 Jul 2021
Cardiac rehab uptake remains low, despite benefits
Estimates from the American Heart Association suggest that only about 20% to 30% of eligible patients ever receive the intervention.
https://immattersacp.org/archives/2022/03/cardiac-rehab-uptake-remains-low-despite-benefits.htm
1 Mar 2022
Adding colchicine after MI may reduce cardiovascular events
While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019
Benefit of anticoagulation for stroke prevention may vary in patients with afib, study finds
An accompanying editorial said the CHA2DS2-VASc cutoff should be considered a starting point for individualized assessment rather than a threshold that applies the same way to everyone.
https://immattersacp.org/weekly/archives/2018/09/25/1.htm
25 Sep 2018
Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction
Among other recommendations, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or an angiotensin receptor-neprilysin inhibitor, along with a beta-blocker and an aldosterone antagonist, is the new recommended therapy to reduce morbidity and mortality in patients with chronic symptomatic heart failure with reduced ejection fraction.
https://immattersacp.org/weekly/archives/2016/05/24/2.htm
24 May 2016
In the News
Cardiology criteria, ICD benefit in the elderly, and other recent news.
https://immattersacp.org/archives/2009/02/in-the-news.htm
1 Feb 2009